Back |
home / stock / inab / inab message board
Subject | By | Source | When |
---|---|---|---|
Impressive day | Awl416 | investorshub | 04/24/2023 5:25:21 PM |
What a beast! | Jess070283 | investorshub | 04/24/2023 5:07:11 PM |
INAB: Maybe I've gone BONKERS, but this little | Invest-in-America | investorshub | 04/24/2023 5:00:21 PM |
This skyrockets to $5 today. This is just getting started. | Hercules1 | investorshub | 04/24/2023 4:48:02 PM |
$INAB: Howdy, Herc!!! Guess us TWO chaps will | Invest-in-America | investorshub | 04/24/2023 4:30:27 PM |
Price target: $14 News is absolutely huge. | Hercules1 | investorshub | 04/24/2023 3:37:52 PM |
$INAB: This is iHub's legendary INVEST-IN-AMERICA[/col | Invest-in-America | investorshub | 04/24/2023 3:23:00 PM |
INAB: Might get a little run-up later | Invest-in-America | investorshub | 04/24/2023 2:46:31 PM |
$INAB The gaining | Jess070283 | investorshub | 04/17/2023 4:29:34 PM |
The gaining up | Invest-in-America | investorshub | 04/17/2023 8:57:36 AM |
News, Short Squeeze, Breakout and More Instantly...
IN8bio Inc. Company Name:
INAB Stock Symbol:
NASDAQ Market:
NEW YORK, May 24, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (NASDAQ:INAB) a clinical-stage biopharmaceutical company developing innovative gamma-del...
NEW YORK, May 24, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced multiple presentations at the International Society for Cell & Gene Therapy 2024, to be held May 28 th ...
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (NASDAQ:INAB) a clinical-stage biopharmaceutical company developing innovative gamma-del...